New Insurance Product Monitoring: Do’s and Don’ts for Actuaries

Launching a new insurance product is a significant achievement, but it’s not the finish line.

‍

‍

While the pre-launch phase of a new insurance product requires strategic planning, its launch marks the start of a critical new chapter. Once your product hits the market, real-world data begins to trickle in, offering opportunities to refine your strategy and identify areas of improvement. However, without a thoughtful approach, that same data can lead you astray.

This article explores the key do’s and don’ts of monitoring your new insurance product after launch. From interpreting early performance signals, to evolving toward traditional actuarial models as data matures, these practical tips will help ensure your new offering succeeds in a competitive market.

Do track insurance conversion rates closely

One of the first metrics to monitor after launch is your product’s conversion rate. It offers early insight into market reception and competitiveness. A sudden spike in insurance conversion rate might seem like a win, but it could also signal underpricing in a particular segment.

Early conversion data can also be volatile and easily influenced by factors like distribution channel behavior or limited sample sizes. That’s why it’s essential to assess data credibility before making changes. Approaches like Lasso Credibility allow insurers to determine when a trend is credible enough to act on, and how much to adjust in response. Without this kind of necessary discipline, it’s easy to overreact and destabilize your pricing strategy.

Don’t let early claims data derail your insurance pricing strategy

Monitoring conversion data is not enough: early claims data can also give insights into a new insurance product’s performance.

‍

It’s tempting to immediately treat initial claims as a clear signal, but early data can be misleading. Acting too quickly may cause more harm than good. While emerging claims trends can offer valuable directional feedback, they often lack the maturity needed for reliable actuarial pricing models.

Rather than reacting immediately, you can use this data to monitor for patterns over time and across segments. A credibility-based modeling approach helps you incorporate new signals at the right pace, striking a balance between responsiveness and stability. It’s about staying alert, not being impulsive.

If all signals point to potential issues, how can you respond without overcommitting? That’s where A/B testing comes in.

Do experiment with A/B testing and stress testing

Where regulations and infrastructure allow, A/B testing can be a powerful tool for refining your post-launch insurance pricing strategy. Testing different pricing structures, marketing messages, or distribution approaches can offer clarity that even the best actuarial risk models can’t fully anticipate.

Modern actuarial tools like Akur8 Pricing’s DEMAND and DEPLOY modules make this easier. They enable actuaries to test live pricing variations, monitor performance in real time, and simulate outcomes under different assumptions, all without disrupting the broader portfolio.

If A/B testing isn’t possible in your market, you can focus your analysis on structured “before/after” comparisons and robust scenario planning.

This type of experimentation or analysis can be especially valuable in the early stages of a new insurance product, when initial performance data is limited. It can also help you share insights and make your case to stakeholders, ultimately facilitating collaboration and stronger decision-making.

Don't work in silos: collaborative actuarial tools are key

Once your product is live, collaboration between teams becomes critical. Pricing actuaries, underwriters, claims analysts, marketers, and product managers all bring unique insights into how the product is performing and why.

Isolated analysis rarely captures the full picture. A change in claim frequency might be due to marketing targeting a different demographic, while a dip in conversion could stem from UX friction. Cross-functional communication can help surface these connections early and adjust accordingly.

Understanding the priorities and decisions of different teams is essential to grasp the broader company stakes. It also helps you adjust your pricing approach in the most sustainable way over time.

Do shift toward traditional insurance pricing models as data matures

As your claims data builds volume and quality, it becomes possible to gradually transition from expert judgment and external benchmarks to internal, experience-based actuarial pricing models.

You can start by refining segmentation with new insights, then recalibrate your base rates as data volumes increase and the credibility of the trends they contain improve. Eventually, you’ll be able to develop peril-level models, incorporate frequency and severity trends, and build elasticity models to understand customer price sensitivity.

Importantly, you should not wait for your data to cross some arbitrary threshold before taking any action. Approaches like Lasso Credibility allow insurers to determine when a trend is credible enough to act on, and how much to adjust in response.

Tools like Akur8 Pricing’s RISK and RATE modules support this progression, enabling actuaries to run insurance pricing models, simulate different pricing impacts and validate assumptions while maintaining agility.

In summary: use data wisely, not reactively

Monitoring a new insurance product is a balancing act. You need to respond to real-world signals, but only when they’re strong and credible enough to warrant change.

The launch of an insurance product is just the beginning of a longer journey. Success in the market will come from a mix of actuarial judgment, rigorous insurance data analysis, and collaboration. With the right mindset and actuarial tools, you can ensure your insurance product evolves into a sustainable, competitive offering.

‍

Want to learn more about best practices for refining the pricing of a new insurance product?